Photocure ASA (OSL:PHO)
Norway
· Delayed Price · Currency is NOK 50.40
+0.60 (1.20%)
May 13, 2025, 10:42 AM CET
Photocure ASA Revenue
Photocure ASA had revenue of 125.34M NOK in the quarter ending March 31, 2025, with 6.19% growth. This brings the company's revenue in the last twelve months to 532.69M, up 3.95% year-over-year. In the year 2024, Photocure ASA had annual revenue of 525.39M with 4.94% growth.
Revenue (ttm)
532.69M
Revenue Growth
+3.95%
P/S Ratio
2.49
Revenue / Employee
5.33M
Employees
101
Market Cap
1.33B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 525.39M | 24.73M | 4.94% |
| Dec 31, 2023 | 500.66M | 107.53M | 27.35% |
| Dec 31, 2022 | 393.13M | 32.59M | 9.04% |
| Dec 31, 2021 | 360.54M | 104.06M | 40.57% |
| Dec 31, 2020 | 256.48M | -25.07M | -8.91% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Medistim ASA | 603.92M |
| Nordhealth AS | 537.23M |
| Vistin Pharma ASA | 440.66M |
| Nykode Therapeutics AS | 104.04M |
| Hofseth BioCare ASA | 265.54M |
| Omda AS | 426.27M |
| Gentian Diagnostics ASA | 158.07M |
| ArcticZymes Technologies ASA | 102.97M |